Who are TherapeuticsMD, Inc.'s main suppliers?

TherapeuticsMD, Inc. (TXMD) key suppliers include: COSETTE-PHARMACEUTICALS-INC, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/TXMD.

Who are TherapeuticsMD, Inc.'s major customers?

TherapeuticsMD, Inc. (TXMD) key customers include: MAYNE-PHARMA, KNIGHT-THERAPEUTICS-INC, THERAMEX-HQ-UK-LIMITED, MAYNE-PHARMA-GROUP, ORANY and 4 more. View the full customer network at chainsifter.com/chain/TXMD.

What sector is TherapeuticsMD, Inc. in?

TherapeuticsMD, Inc. (TXMD) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

TherapeuticsMD, Inc. Suppliers, Customers & Supply Chain (TXMD)

3Suppliers

9Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

TherapeuticsMD, Inc. (TXMD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships

4Distinct source URLs

9High confidence

0.794Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

TherapeuticsMD, Inc. Suppliers

Ticker	Name	Confidence	Evidence
COSETTE-PHARMACEUTICALS-INC	COSETTE-PHARMACEUTICALS-INC	85%	including as a result of Mayne Pharma Group’s potential sale to Cosette Pharmaceuticals, Inc.
ORANY	ORANY	72%	of the net working capital allowance for returns. In August 2024, the Company received information from Mayne Pharma pertaining to the net working capital allowance for returns that differs significa…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from TXMD graph: of the net working capital allowance for returns. In August 2024, the Company received information from Mayne Pharma…

TherapeuticsMD, Inc. Customers

Ticker	Name	Confidence	Evidence
MAYNE-PHARMA	MAYNE-PHARMA	92%	The rant of the licenses under the Mayne License Agreement was (i) a cash payment of $140.0 million at closing, (ii) a cash payment of approximately $12.1 million at closing for the acquisition of ne…
KNIGHT-THERAPEUTICS-INC	KNIGHT-THERAPEUTICS-INC	90%	In July 2018, we entered into a license and supply agreement (the "Knight License Agreement") with Knight Therapeutics Inc. ("Knight") pursuant to which we granted Knight an exclusive license to comm…
THERAMEX-HQ-UK-LIMITED	THERAMEX-HQ-UK-LIMITED	90%	In June 2019, we entered into an exclusive license and supply agreement (the "Theramex License Agreement") with Theramex HQ UK Limited ("Theramex") to commercialize IMVEXXY and BIJUVA outside of the …
MAYNE-PHARMA-GROUP	MAYNE-PHARMA-GROUP	80%	If Mayne Pharma's sales of Licensed Products grow more slowly than expected or decline, including as a result of Mayne Pharma Group's potential sale to Cosette Pharmaceuticals, Inc.
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from TXMD graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from TXMD graph: Reciprocal relationship from ORAN…
ORANY	ORANY	72%	al product is a one-year ring-shaped contraceptive vaginal system (“CVS”) and the first and only patient-controlled, procedure-free, reversible prescription contraceptive that can prevent pregnancy f…
CATALENT-PHARMA-SOLUTIONS-LLC	CATALENT-PHARMA-SOLUTIONS-LLC	62%	ir opinion that accompanies our audited consolidated financial statements as of and for the year ended December 31, 2025, indicating such. As of December 31, 2025, we had $7.5 million in cash and cas…
TEVA	Teva Pharmaceutical Industries Limited	62%	Reciprocal relationship from TEVA graph: Reciprocal relationship from TXMD graph: Reciprocal relationship from TEVA graph: Reciprocal relationship from TXMD graph: Reciprocal relationship from TEVA g…
TEVA-PHARMACEUTICALS-USA-INC	TEVA-PHARMACEUTICALS-USA-INC	62%	al product is a one-year ring-shaped contraceptive vaginal system (“CVS”) and the first and only patient-controlled, procedure-free, reversible prescription contraceptive that can prevent pregnancy f…

TherapeuticsMD, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
TXMD-DEBT-13175	Warrants outstanding: 6534687	90%	xbrl warrant detail from xbrl 2023-12-31.
TXMD-DEBT-13176	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2012-12-31.
TXMD-DEBT	Debt stack $93.6M	90%	Market cache reports total debt of $93.6M.

TherapeuticsMD, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for TherapeuticsMD, Inc..

TherapeuticsMD, Inc. Ownership

Holder	Name	Confidence	Evidence
TXMD-OWNER-RUBRIC-CAPITAL-MANAGEMENT-LP	Rubric Capital Management LP	90%	13F overlay lists Rubric Capital Management LP as top holder; 51 tracked holders.

TherapeuticsMD, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
TEVA	Teva Pharmaceutical Industries Limited	100.00	1	['customer']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
BCDRF	Banco Santander, S.A.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
AMXOF	AMERICA MOVIL SAB DE CV/	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
AMRX	Amneal Pharmaceuticals, Inc.	50.00	2
BDRX	Biodexa Pharmaceuticals Plc	50.00	2

TherapeuticsMD, Inc. Supply Chain